Kinetic characterization of inosine monophosphate dehydrogenase of Leishmania donovani

Molecular and Biochemical Parasitology

Volumn 152, Issue 1, 2007, Pages 11-21

  Dobie, Fredrick ^a   Berg, Amanda ^c   Boitz, Jan M ^b   Jardim, Armando ^a  

^a MCGILL UNIVERSITY   (Canada)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NONE

Author keywords

IMPDH; Inosine monophosphate dehydrogenase; Leishmania; Purine salvage

Indexed keywords

INOSINATE DEHYDROGENASE; INOSINATE DEHYDROGENASE INHIBITOR; MYCOPHENOLIC ACID; NUCLEOTIDE; PROTOZOAL PROTEIN; RECEPTOR;

ARTICLE; CELLULAR DISTRIBUTION; CONCENTRATION (PARAMETERS); CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SUBSTRATE; ESCHERICHIA COLI; GENE OVEREXPRESSION; IMMUNOFLUORESCENCE MICROSCOPY; LEISHMANIA DONOVANI; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

5'-GUANYLIC ACID; AMINO ACID SEQUENCE; ANIMALS; ENZYME INHIBITORS; ESCHERICHIA COLI; INOSINE MONOPHOSPHATE; LEISHMANIA DONOVANI; MICROBODIES; MICROSCOPY, CONFOCAL; MYCOPHENOLIC ACID; NAD; PHYLOGENY; PROTEIN BINDING; PROTOZOAN PROTEINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT PROTEINS; RIBONUCLEOTIDES; SEQUENCE ALIGNMENT; SUBCELLULAR FRACTIONS; SUBSTRATE SPECIFICITY;

LEISHMANIA DONOVANI; PROTOZOA; TRYPANOSOMATIDAE;

EID: 33846339422     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbiopara.2006.11.007     Document Type: Article

References (53)

1. Szekeres T., Fritzer M., Pillwein K., Felzmann T., and Chiba P. Cell cycle dependent regulation of IMP dehydrogenase activity and effect of tiazofurin. Life Sci 51 (1992) 1309-1315
2. Natsumeda Y., Ikegami T., Murayama K., and Weber G. De novo guanylate synthesis in the commitment to replication in hepatoma 3924A cells. Cancer Res 48 (1988) 507-511
3. Collart F.R., Chubb C.B., Mirkin B.L., and Huberman E. Increased inosine-5′-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines. Cancer Res 52 (1992) 5826-5828
4. Collart F.R., and Huberman E. Cloning and sequence analysis of the human and Chinese hamster inosine-5′-monophosphate dehydrogenase cDNAs. J Biol Chem 263 (1988) 15769-15772
5. Streeter D.G., Witkowski J.T., Khare G.P., et al. Mechanism of action of 1-β-d-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent. Proc Natl Acad Sci USA 70 (1973) 1174-1178
6. Gish R.G. Treating HCV with ribavirin analogues and ribavirin-like molecules. J Antimicrob Chemother 57 (2006) 8-13
7. Allison A.C., and Eugui E.M. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF). Clin Transplant 10 (1996) 77-84
8. Sintchak M.D., Fleming M.A., Futer O., et al. Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid. Cell 85 (1996) 921-930
9. Farazi T., Leichman J., Harris T., Cahoon M., and Hedstrom L. Isolation and characterization of mycophenolic acid-resistant mutants of inosine-5′-monophosphate dehydrogenase. J Biol Chem 272 (1997) 961-965
10. Link J.O., and Straub K. Trapping of an IMP dehydrogenase-substrate covalent intermediate by mycophenolic acid. J Am Chem Soc 118 (1996) 2091-2092
11. Zhang R., Evans G., Rotella F.J., et al. Characteristics and crystal structure of bacterial inosine-5′-monophosphate dehydrogenase. Biochemistry 38 (1999) 4691-4700
12. Sullivan Jr. W.J., Dixon S.E., Li C., Striepen B., and Queener S.F. IMP dehydrogenase from the protozoan parasite Toxoplasma gondii. Antimicrob Agents Chemother 49 (2005) 2172-2179
13. Umejiego N.N., Li C., Riera T., Hedstrom L., and Striepen B. Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design. J Biol Chem 279 (2004) 40320-40327
14. Hedstrom L., and Wang C.C. Mycophenolic acid and thiazole adenine dinucleotide inhibition of Tritrichomonas foetus inosine 5′-monophosphate dehydrogenase: implications on enzyme mechanism. Biochemistry 29 (1990) 849-854
15. Hager P.W., Collart F.R., Huberman E., and Mitchell B.S. Recombinant human inosine monophosphate dehydrogenase type I and type II proteins. Purification and characterization of inhibitor binding. Biochem Pharmacol 49 (1995) 1323-1329
16. Prosise G.L., and Luecke H. Crystal structures of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs: a structural basis for the random-in ordered-out kinetic mechanism. J Mol Biol 326 (2003) 517-557
17. Prosise G.L., Wu J.Z., and Luecke H. Crystal structure of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with the inhibitor ribavirin monophosphate reveals a catalysis-dependent ion-binding site. J Biol Chem 277 (2002) 50654-50659
18. + orients the active site loop for catalysis. Biochemistry 41 (2002) 13309-13317
19. Gan L., Seyedsayamdost M.R., Shuto S., Matsuda A., Petsko G.A., and Hedstrom L. The immunosuppressive agent mizoribine monophosphate forms a transition state analogue complex with inosine monophosphate dehydrogenase. Biochemistry 42 (2003) 857-863
20. McMillan F.M., Cahoon M., White A., Hedstrom L., Petsko G.A., and Ringe D. Crystal structure at 2.4 Å resolution of Borrelia burgdorferi inosine 5′-monophosphate dehydrogenase: evidence of a substrate-induced hinged-lid motion by loop 6. Biochemistry 39 (2000) 4533-4542
21. Allen T., Hwang H.Y., Wilson K., Hanson S., Jardim A., and Ullman B. Cloning and expression of the adenine phosphoribosyltransferase from Leishmania donovani. Mol Biochem Parasitol 74 (1995) 99-103
22. Allen T.E., Hwang H.Y., Jardim A., Olafson R., and Ullman B. Cloning and expression of the hypoxanthine-guanine phosphoribosyltransferase from Leishmania donovani. Mol Biochem Parasitol 73 (1995) 133-143
23. LaFon S.W., Nelson D.J., Berens R.L., and Marr J.J. Purine and pyrimidine salvage pathways in Leishmania donovani. Biochem Pharmacol 31 (1982) 231-238
24. Looker D.L., Berens R.L., and Marr J.J. Purine metabolism in Leishmania donovani amastigotes and promastigotes. Mol Biochem Parasitol 9 (1983) 15-28
25. Boitz J.M., and Ullman B. A conditional mutant deficient in hypoxanthine-guanine phosphoribosyltransferase and xanthine phosphoribosyltransferase validates the purine salvage pathway of Leishmania donovani. J Biol Chem 281 (2006) 16084-16089
26. Wilson K., Collart F.R., Huberman E., Stringer J.R., and Ullman B. Amplification and molecular cloning of the IMP dehydrogenase gene of Leishmania donovani. J Biol Chem 266 (1991) 1665-1671
27. Wilson K., Beverley S.M., and Ullman B. Cloning of the gene encoding Leishmania donovani S-adenosylhomocysteine hydrolase, a potential target for antiparasitic chemotherapy. Mol Biochem Parasitol 55 (1992) 197-206
28. Craig III S.P., Yuan L., Kuntz D.A., McKerrow J.H., and Wang C.C. High level expression in Escherichia coli of soluble, enzymatically active schistosomal hypoxanthine/guanine phosphoribosyltransferase and trypanosomal ornithine decarboxylase. Proc Natl Acad Sci USA 88 (1991) 2500-2504
29. Gill S.C., and von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal Biochem 182 (1989) 319-326
30. Cornish-Bowden A., and Eisenthal R. Statistical considerations in the estimation of enzyme kinetic parameters by the direct linear plot andother methods. Biochem J 139 (1974) 721-730
31. Henderson P.J.F. A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors. Biochem J 127 (1972) 321-333
32. Jardim A., Liu W., Zheleznova E., and Ullman B. Peroxisomal targeting signal-1 receptor protein PEX5 from Leishmania donovani. Molecular, biochemical, and immunocytochemical characterization. J Biol Chem 275 (2000) 13637-13644
33. Antonino L.C., Straub K., and Wu J.C. Probing the active site of human IMP dehydrogenase using halogenated purine riboside 5′-monophosphates and covalent modification reagents. Biochemistry 33 (1994) 1760-1765
34. Huete-Perez J.A., Wu J.C., Whitby F.G., and Wang C.C. Identification of the IMP binding site in the IMP dehydrogenase from Tritrichomonas foetus. Biochemistry 34 (1995) 13889-13894
35. Letunic I., Copley R.R., Pils B., Pinkert S., Schultz J., and Bork P. SMART 5: domains in the context of genomes and networks. Nucl Acids Res 34 (2006) D257-D260
36. Shin P.K., and Seo J.-H. Analysis of E. coli phoA-lacZ fusion gene expression inserted into a multicopy plasmid and host cell's chromosome. Biotechnol Bioeng 36 (1990) 1097-1104
37. Kerr K., Cahoon M., Bosco M., and Hedstrom D.A.L. Monovalent cation activation in Escherichia coli inosine 5′-monophosphate dehydrogenase. Arch Biochem Biophys 375 (2000) 131-137
38. Kerr K.M., and Hedstrom L. The roles of conserved carboxylate residues in IMP dehydrogenase and identification of a transition state analog. Biochemistry 36 (1997) 13365-13373
39. Zhou X., Cahoon M., Rosa P., and Hedstrom L. Expression, purification, and characterization of inosine 5′-monophosphate dehydrogenase from Borrelia burgdorferi. J Biol Chem 272 (1997) 21977-21981
40. Sommer J.M., and Wang C.C. Targeting proteins to the glycosomes of African trypanosomes. Annu Rev Microbiol 48 (1994) 105-138
41. Holmes E.W., Pehlke D.M., and Kelley W.N. Human IMP dehydrogenase. Kinetics and regulatory properties. Biochim Biophys Acta 364 (1973) 209-217
42. Wang W., and Hedstrom L. Kinetic mechanism of human inosine 5′-monophosphate dehydrogenase type II: random addition of substrates and ordered release of products. Biochemistry 36 (1997) 8479-8483
43. Guillen Schlippe Y.V., Riera T.V., Seyedsayamdost M.R., and Hedstrom L. Substitution of the conserved Arg-Tyr dyad selectively disrupts the hydrolysis phase of the IMP dehydrogenase reaction. Biochemistry 43 (2004) 4511-4521
44. Guillen Schlippe Y.V., and Hedstrom L. Guanidine derivatives rescue the Arg418Ala mutation of Tritrichomonas foetus IMP dehydrogenase. Biochemistry 44 (2005) 16695-16700
45. Kohler G.A., Gong X., Bentink S., et al. The functional basis of mycophenolic acid resistance in Candida albicans IMP dehydrogenase. J Biol Chem 280 (2005) 11295-11302
46. McLean J.E., Hamaguchi N., Belenky P., Mortimer S.E., Stanton M., and Hedstrom L. Inosine 5′-monophosphate dehydrogenase binds nucleic acids in vitro and in vivo. Biochem J 379 (2004) 243-251
47. Cornuel J.F., Moraillon A., and Gueron M. Participation of yeast inosine 5′-monophosphate dehydrogenase in an in vitro complex with a fragment of the C-rich telomeric strand. Biochimie 84 (2002) 279-289
48. Jardim A., Bergeson S.E., Shih S., et al. Xanthine phosphoribosyltransferase from Leishmania donovani. Molecular cloning, biochemical characterization, and genetic analysis. J Biol Chem 274 (1999) 34403-34410
49. Shih S., Hwng H.-Y., Carter D., Stenberg P., and Ullman B. Localization and targeting of the Leishmania donovani hypoxanthine-guanine phosphoribosyltransferase to the glycosome. J Biol Chem 273 (1998) 1534-2154
50. Zarella-Boitz J.M., Rager N., Jardim A., and Ullman B. Subcellular localization of adenine and xanthine phosphoribosyltransferases in Leishmania donovani. Mol Biochem Parasitol 134 (2004) 43-51
51. Opperdoes F.R., and Szikora J.P. In silico prediction of the glycosomal enzymes of Leishmania major and trypanosomes. Mol Biochem Parasitol 147 (2006) 193-206
52. Ji Y., Gu J., Makhov A.M., Griffith J.D., and Mitchell B.S. Regulation of the interaction of inosine monophosphate dehydrogenase with mycophenolic acid by GTP. J Biol Chem 281 (2006) 206-212
53. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., and Higgins D.G. Nucl Acids Res 25 (1997) 4876-4882